Conde-Knape makes the future of pharmaceuticals possible at Novo Nordisk

The world has been her playground, and now, Karin Conde-Knape is using her international experiences as the woman in charge of Global Drug Discovery at Novo Nordisk.

Karin Conde-Knape became the senior vice president of global drug discovery at Novo Nordisk a little over a year ago. Here, she's in charge of preliminary research withinin several therapy areas that are of interest to the pharmaceutical giant.

"If I had to be more specific, I would say it's our responsibility to discover new potential treatments in the disease areas that are relevant to Novo Nordisk," Conde-Knape says.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today